Fig. 1From: Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patientsSurvival analyses according to presence of disseminated tumor cells (DTCs) in bone marrow (BM) samples obtained prior to surgery (a and b) and 3 weeks and/or 6 months after surgery (c and d) from 191 operable breast cancer patients with a median follow-up of 15.3 yearsBack to article page